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5Dear Editor,
A 23-year-old boy was hospitalized for dyspnea with mild
fever. Chest x-ray documented left pleural effusion. Cul-
tures from thoracentesis grew out Acremonium strictum and
intravenous liposomal amphotericin B was given at a dose
of 200 mg  daily. On treatment, fever subsided but dyspnea
worsened. Whole-body CT scan showed multiple bilateral
lung nodules, systemic lymphadenopathies and a mass over
the left testis. Biopsies from an enlarged supraclavicular
lymph node revealed metastatic testicular teratocarcinoma.
Chemotherapy with PEB was started but, at day 70 from
admission, the patient died of acute respiratory distress
syndrome.
Acremonium (formerly Cephalosporium) species are ﬁlamen-
tous fungi commonly found in soil and plants.1 Of note,
cephalosporins were isolated from this class of hyphomycetes
in 1951. In humans, they are rare opportunistic pathogens,
mainly causing in immunocompetent individuals superﬁcial
infections such as foot mycetoma, keratitis and onychomy-
cosis. Invasive infections are exceptional since only a dozen
reports exist in the pertinent literature: such conditions usu-
ally occur in severely immunocompromised patients with
hematologic diseases or solid tumors and include fungemia,
meningitis, brain abscess, peritonitis and pyomyositis.1–5 Pro-
tracted neutropenia, corticosteroid therapy and the presence
of a central venous catheter represent the principal predispos-
ing factors.2 As for the respiratory system, Acremonium strictum
has been associated with two types of lesions: multiple bilat-
eral nodules with no halo sign (4 cases) and pleuritis (2 cases
including ours).1–5 The prognosis of invasive infection from
Acremonium spp. is usually unfavorable with a mortality rate
3of 30%. The reasons of such a poor outcome are related to
the delay in diagnosis and speciﬁc therapy, lack of standard
treatment because of the rarity of such infections, and the
little susceptibility to the common antifungal agents such asﬂuconazole and ﬂucytosine. Liposomal amphotericin B and
the newer azoles such as posoconazole are the most effective
drugs.2
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